{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:33:17Z","timestamp":1772447597376,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.transproceed.2007.03.064","type":"journal-article","created":{"date-parts":[[2007,6,17]],"date-time":"2007-06-17T23:32:29Z","timestamp":1182123149000},"page":"1386-1391","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Safety of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Recipients: Pooled Data From Three 12-Month Multicenter, Open-Label, Prospective Studies"],"prefix":"10.1016","volume":"39","author":[{"given":"C.","family":"Legendre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2007.03.064_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.324.7336.530","article-title":"Renal transplantation","volume":"324","author":"Andrews","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.transproceed.2007.03.064_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2007.03.064_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.03.064_bib4","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.03.064_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2007.03.064_bib6","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2007.03.064_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.03.064_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-2277.2004.tb00394.x","article-title":"Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil","volume":"17","author":"Hardinger","year":"2001","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2007.03.064_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","article-title":"Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients","volume":"19","author":"Tierce","year":"2005","journal-title":"Clinical Transplant"},{"issue":"Suppl 11","key":"10.1016\/j.transproceed.2007.03.064_bib11","first-page":"242","article-title":"Consequences of immunosuppression minimization following diagnosis of gastrointestinal complications in renal transplant","volume":"5","author":"Schnitzler","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.transproceed.2005.01.063","article-title":"Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients","volume":"37","author":"Salvadori","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.03.064_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safety administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.transproceed.2004.12.048","article-title":"Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study","volume":"37","author":"Budde","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.03.064_bib16","doi-asserted-by":"crossref","first-page":"521S","DOI":"10.1016\/j.transproceed.2004.01.037","article-title":"Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study","volume":"36","author":"Nashan","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.03.064_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1600-6143.2006.01291.x","article-title":"Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study","volume":"6","author":"Kamar","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 8","key":"10.1016\/j.transproceed.2007.03.064_bib18","first-page":"218","article-title":"Enteric-coated mycophenolate sodium in combination with optimized Neoral dosing, basiliximab, and steroids results in good efficacy and renal function in renal transplant recipients in the first 6 months","volume":"4","author":"Cibrik","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 11","key":"10.1016\/j.transproceed.2007.03.064_bib19","first-page":"461","article-title":"Reduced cyclosporin exposure is safe and efficacious in combination with basiliximab, enteric-coated mycophenolate sodium, and steroids","volume":"5","author":"Budde","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2007.03.064_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 11","key":"10.1016\/j.transproceed.2007.03.064_bib22","first-page":"191","article-title":"Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: results of a 12-month multicentre, open-label, prospective study","volume":"5","author":"Vitko","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.03.064_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.TP.0000089006.00653.64","article-title":"Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 11","key":"10.1016\/j.transproceed.2007.03.064_bib24","first-page":"242","article-title":"Consequences of immunosuppression minimization following diagnosis of gastrointestinal complications in renal transplant","volume":"5","author":"Schnitzler","year":"2005","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T10:53:05Z","timestamp":1546771985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134507003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0041134507003983"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2007.03.064","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}